Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Rimonabant

Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)

Sanofi · Phase 3 · Completed · Enrollment 1507

NCT00386061

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Registry arm not namedn/rn/rn/rn/r

Not shown

  • Registry arm not named: endpoint not reported